Home / ORMP.TA : TLV

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does ORMP.TA make money? Does ORMP.TA have pricing power? What's the Earnings Whisper? Will ORMP.TA profit more as the business scales? What is ORMP.TA's management track record? Is ORMP.TA's current price justified?

Oramed Pharmaceuticals Inc.

ILA 1311.00 +$404.10 (+44.56%)

TLV · 30 Oct 2026 11:44 UTC

Previous Close

ILA 1310.00

Day Range

ILA 1310.00ILA 1350.00

Year Range

ILA 7.00ILA 1742.00

Market Cap

545.34M

AVG Volume

6.25K

Trailing/Forward PE

0.97/-

PEG ratio

-0

Dividend Yield

6.08%

Next Earnings Date

2026-11-12

Primary Exchange

Tel Aviv Stock Exchange

Revenue (USD) · Q

ORMP.TA Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	2M
24 Q4	0
23 Q3	0
23 Q2	674K
23 Q1	666K

Net Income (USD) · Q

ORMP.TA Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	77.56M
26 Q1	38.55M
25 Q4	10.01M
25 Q3	48.4M
25 Q2	13.29M
25 Q1	-7.64M
24 Q4	-10.19M
23 Q3	-3.22M
23 Q2	-1.19M
23 Q1	-1.8M

Operating Income (USD) · Q

ORMP.TA Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-2.74M
26 Q1	-3.68M
25 Q4	-5.67M
25 Q3	-2.43M
25 Q2	-2.49M
25 Q1	-4.5M
24 Q4	-3.6M
23 Q3	-2.89M
23 Q2	-3.79M
23 Q1	-5.21M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (USD) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Oramed Pharmaceuticals Inc.

Earnings: ORMP.TA

Video analysis: ORMP.TA

News: ORMP.TA

Similar companies